Proto Labs, Inc. (NYSE: PRLB) is a Industrials company (Manufacturing - Miscellaneous) with a market capitalization of $1.5B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Proto Labs, Inc. had a Maz Rating of 4.86 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Financial Health (4.99), among the strongest in its sector; its weakest was Valuation (1.21), among the most expensive in its sector. The other factors: Momentum 4.75 (among the strongest in its sector); Growth 4.14 (above most of its sector); Profitability 3.74 (above most of its sector). The current rating is for members: log in to see it.
At $64.29, Proto Labs, Inc. trades at 43.9x trailing earnings, 2.6x sales and 2.2x book value, with an EV/EBITDA of 17.3. Over the last twelve months it generated about $581M of revenue and $35M of net income. It runs a gross margin of 45.2%, an operating margin of 7.7% and a net margin of 6.0%. It shows return on equity of 5.1%, return on invested capital of 4.4% and a free cash flow yield of 3.2%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 3.65. Over the past 52 weeks the share price ranged from $46.07 to $99.96, with a beta of 1.50.
Proto Labs, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 6 Buy and 11 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.